A comprehensive view of Genetic Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Regeneron Pharma Applies for Patent on Non-Human Animals Expressing Ph-Sensitive Immunoglobulin Sequences
Published: May 08, 2024 by Husbandry Patent News
PacBio announces PureTarget panel to thoroughly examine 20 genes linked to severe neurological conditions; panel offers streamlined methodology for quicker processing of thousands of samples worldwide and will be available from March 25
Published: March 13, 2024 by Zack's Commentary
Bristol-Myers Squibb Champions Genetic Heart Disease Awareness and Clinical Trial Advancement Across Global Divisions
Published: March 07, 2024 by Industry Intelligence Inc.
Biogen's QALSODY, a treatment for the rare genetic form of ALS known as SOD1-ALS, receives a positive recommendation from CHMP; if approved, QALSODY would become the first treatment to target a genetic cause of ALS in the EU
Published: February 23, 2024 by GlobeNewswire Europe
Pierre Fabre Laboratories marks Rare Disease Day on Feb. 29; it highlights its partnerships and innovative treatments for rare genetic diseases in children, such as its work with EspeRare Foundation to treat XLHED, Atara Biotherapeutics for EBV+ PTLD
Published: February 23, 2024 by PR Newswire

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count